BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16518845)

  • 1. Chromosome 16 tumor-suppressor genes in breast cancer.
    Rakha EA; Green AR; Powe DG; Roylance R; Ellis IO
    Genes Chromosomes Cancer; 2006 Jun; 45(6):527-35. PubMed ID: 16518845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
    van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
    Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
    Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.
    Frengen E; Rocca-Serra P; Shaposhnikov S; Taine L; Thorsen J; Bepoldin C; Krekling M; Lafon D; Aas KK; El Monéim AA; Johansen H; Longy M; Prydz H; Dorion-Bonnet F
    Genomics; 2000 Dec; 70(3):273-85. PubMed ID: 11161777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
    Green AR; Krivinskas S; Young P; Rakha EA; Paish EC; Powe DG; Ellis IO
    Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.
    Venter DJ; Ramus SJ; Hammet FM; de Silva M; Hutchins AM; Petrovic V; Price G; Armes JE
    Cancer Genet Cytogenet; 2005 Jul; 160(2):134-40. PubMed ID: 15993269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.
    Kremmidiotis G; Baker E; Crawford J; Eyre HJ; Nahmias J; Callen DF
    Genomics; 1998 May; 49(3):467-71. PubMed ID: 9615235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene.
    Zeng WR; Watson P; Lin J; Jothy S; Lidereau R; Park M; Nepveu A
    Oncogene; 1999 Mar; 18(11):2015-21. PubMed ID: 10208423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
    Bièche I; Champème MH; Lidereau R
    Clin Cancer Res; 1995 Jan; 1(1):123-7. PubMed ID: 9815894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers.
    Armes JE; Hammet F; de Silva M; Ciciulla J; Ramus SJ; Soo WK; Mahoney A; Yarovaya N; Henderson MA; Gish K; Hutchins AM; Price GR; Venter DJ
    Oncogene; 2004 Jul; 23(33):5697-702. PubMed ID: 15184884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
    Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
    BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotype of pediatric rhabdomyosarcoma.
    Visser M; Sijmons C; Bras J; Arceci RJ; Godfried M; Valentijn LJ; Voûte PA; Baas F
    Oncogene; 1997 Sep; 15(11):1309-14. PubMed ID: 9315099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers.
    Tai AL; Mak W; Ng PK; Chua DT; Ng MY; Fu L; Chu KK; Fang Y; Qiang Song Y; Chen M; Zhang M; Sham PC; Guan XY
    Cancer Res; 2006 Apr; 66(8):4133-8. PubMed ID: 16618734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
    Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
    Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.
    Angeloni D; ter Elst A; Wei MH; van der Veen AY; Braga EA; Klimov EA; Timmer T; Korobeinikova L; Lerman MI; Buys CH
    Genes Chromosomes Cancer; 2006 Jul; 45(7):676-91. PubMed ID: 16607615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.